| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9646280 | Schizophrenia Research | 2005 | 9 Pages |
Abstract
Elevations of S100B in elderly chronic schizophrenic patients may be related to an active disease process lasting until old-age. Correlations point to the impact of S100B in neuroplasticity and ageing. Post-mortem studies should clarify the presence of altered S100B function in the brain and its relationship to neuroplastic or neurodegenerative processes.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Andrea Schmitt, Thomas Bertsch, Uwe Henning, Heike Tost, Ansgar Klimke, Fritz A. Henn, Peter Falkai,